Previous close | 3.8780 |
Open | 3.9040 |
Bid | 3.9060 x 0 |
Ask | 4.0620 x 0 |
Day's range | 3.9040 - 3.9040 |
52-week range | 1.0350 - 4.4180 |
Volume | |
Avg. volume | 799 |
Market cap | 210.038M |
Beta (5Y monthly) | 1.71 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.5600 |
Earnings date | 31 July 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 50.86 |
Shareholders of G1 Therapeutics, Inc. ( NASDAQ:GTHX ) will be pleased this week, given that the stock price is up 13...
G1 Therapeutics ( NASDAQ:GTHX ) First Quarter 2024 Results Key Financial Results Revenue: US$14.5m (up 12% from 1Q...
G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript May 1, 2024 G1 Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.19. GTHX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]